Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Nicotine Delivery Systems | 6 | 2023 | 46 | 2.000 |
Why?
|
| Nicotine | 8 | 2024 | 91 | 1.460 |
Why?
|
| Myocytes, Cardiac | 6 | 2020 | 22 | 1.150 |
Why?
|
| Nicotinic Agonists | 2 | 2019 | 24 | 0.780 |
Why?
|
| Vaping | 2 | 2019 | 20 | 0.770 |
Why?
|
| Animals | 15 | 2025 | 1369 | 0.740 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 196 | 0.740 |
Why?
|
| Mice | 13 | 2025 | 555 | 0.680 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 11 | 0.670 |
Why?
|
| Stroke Volume | 1 | 2019 | 19 | 0.630 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 17 | 0.630 |
Why?
|
| Atherosclerosis | 1 | 2019 | 26 | 0.620 |
Why?
|
| Transcription Factors | 2 | 2009 | 32 | 0.580 |
Why?
|
| Diet, High-Fat | 4 | 2020 | 46 | 0.500 |
Why?
|
| Oxidative Stress | 7 | 2024 | 92 | 0.490 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2009 | 2 | 0.390 |
Why?
|
| Cyclins | 2 | 2009 | 7 | 0.390 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 149 | 0.360 |
Why?
|
| RNA-Binding Proteins | 3 | 2023 | 10 | 0.350 |
Why?
|
| Fatty Liver | 3 | 2024 | 52 | 0.340 |
Why?
|
| Male | 9 | 2024 | 2620 | 0.320 |
Why?
|
| Phenotype | 2 | 2023 | 62 | 0.320 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 1 | 0.320 |
Why?
|
| Apoptosis | 3 | 2020 | 117 | 0.310 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2007 | 1 | 0.270 |
Why?
|
| Cardiomegaly | 1 | 2007 | 3 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 22 | 0.270 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2024 | 28 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 12 | 0.250 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2025 | 2 | 0.250 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2025 | 17 | 0.240 |
Why?
|
| Neuroprotective Agents | 1 | 2025 | 14 | 0.240 |
Why?
|
| Cotinine | 3 | 2020 | 19 | 0.240 |
Why?
|
| Niacinamide | 1 | 2024 | 5 | 0.220 |
Why?
|
| Pyridinium Compounds | 1 | 2024 | 6 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2019 | 112 | 0.220 |
Why?
|
| Humans | 6 | 2025 | 4931 | 0.220 |
Why?
|
| Lipolysis | 1 | 2023 | 11 | 0.210 |
Why?
|
| Mice, Obese | 2 | 2020 | 16 | 0.210 |
Why?
|
| Cytokines | 1 | 2023 | 60 | 0.210 |
Why?
|
| Endoribonucleases | 1 | 2023 | 4 | 0.210 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 11 | 0.200 |
Why?
|
| Myocardium | 1 | 2020 | 19 | 0.170 |
Why?
|
| Heart | 1 | 2020 | 21 | 0.170 |
Why?
|
| Smoking | 1 | 2020 | 59 | 0.170 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 62 | 0.170 |
Why?
|
| Aerosols | 1 | 2019 | 11 | 0.160 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 8 | 0.160 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 5 | 0.160 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 7 | 0.160 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 19 | 0.160 |
Why?
|
| Transcriptome | 1 | 2019 | 15 | 0.160 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 33 | 0.160 |
Why?
|
| Behavior, Animal | 1 | 2019 | 28 | 0.160 |
Why?
|
| Mutation | 1 | 2019 | 51 | 0.160 |
Why?
|
| Diet, Western | 1 | 2019 | 5 | 0.160 |
Why?
|
| Cyclin T | 2 | 2009 | 2 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 51 | 0.150 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 2018 | 4 | 0.150 |
Why?
|
| Benzamides | 1 | 2018 | 9 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2019 | 98 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2018 | 162 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 83 | 0.130 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2020 | 21 | 0.110 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2013 | 1 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2025 | 101 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2013 | 22 | 0.110 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2013 | 1 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 41 | 0.100 |
Why?
|
| RNA Polymerase II | 1 | 2009 | 1 | 0.080 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2009 | 5 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 6 | 0.080 |
Why?
|
| RNA | 1 | 2009 | 18 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 13 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2007 | 20 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2007 | 21 | 0.070 |
Why?
|
| Rats | 1 | 2007 | 373 | 0.060 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2025 | 1 | 0.060 |
Why?
|
| Motor Neurons | 1 | 2025 | 3 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2025 | 20 | 0.060 |
Why?
|
| High Fructose Corn Syrup | 1 | 2024 | 5 | 0.060 |
Why?
|
| Liver | 1 | 2024 | 139 | 0.050 |
Why?
|
| Hep G2 Cells | 1 | 2023 | 6 | 0.050 |
Why?
|
| Palmitates | 1 | 2023 | 5 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2023 | 19 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 9 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 18 | 0.040 |
Why?
|
| Echocardiography | 1 | 2020 | 14 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2020 | 15 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2020 | 76 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 5 | 0.040 |
Why?
|
| Pregnancy | 1 | 2020 | 417 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 10 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 11 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 18 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 53 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2019 | 86 | 0.040 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2018 | 6 | 0.040 |
Why?
|
| Caspases | 1 | 2016 | 15 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 8 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 7 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 55 | 0.030 |
Why?
|
| Models, Biological | 1 | 2016 | 46 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2013 | 4 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 12 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 3 | 0.030 |
Why?
|
| Mitochondria | 1 | 2013 | 21 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 1 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 5 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 5 | 0.030 |
Why?
|
| RNA Interference | 1 | 2013 | 10 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 15 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 5 | 0.030 |
Why?
|
| Female | 1 | 2020 | 2964 | 0.030 |
Why?
|
Espinoza-Derout's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_